Evidence map›Paper›PMID 39899638›Full record

ArticlePLOS digital health2025

Comparison of anonymization techniques regarding statistical reproducibility.

David Pau, Camille Bachot, Charles Monteil, Laetitia Vinet, Mathieu Boucher, Nadir Sella, Romain Jegou

Abstract read
In one paragraph

Article in PLOS digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David PauMedical Evidence and Data Science Unit, Roche, Boulogne-Billancourt, France.ORCID https://orcid.org/0000-0001-7664-4521
Camille BachotMedical Evidence and Data Science Unit, Roche, Boulogne-Billancourt, France.
Charles MonteilInformatics Department, Roche, Boulogne-Billancourt, France.
Laetitia VinetDepartment of Statistics, Keyrus Life Science, Nantes, France.
Mathieu BoucherDepartment of Statistics, Keyrus Life Science, Nantes, France.
Nadir SellaInstitut Roche, Roche, Boulogne-Billancourt, France.
Romain JegouDepartment of Statistics, Keyrus Life Science, Nantes, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnonymization opens up innovative ways of using secondary data without the requirements of the GDPR, as anonymized data does not affect anymore the privacy of data subjects. Anonymization requires data alteration, and this project aims to compare the ability of such privacy protection methods to maintain reliability and utility of scientific data for secondary research purposes.

methodsThe French data protection authority (CNIL) defines anonymization as a processing activity that consists of using methods to make impossible any identification of people by any means in an irreversible manner. To answer project's objective, a series of analyses were performed on a cohort, and reproduced on four sets of anonymized data for comparison. Four assessment levels were used to evaluate impact of anonymization: level 1 referred to the replication of statistical outputs, level 2 referred to accuracy of statistical results, level 3 assessed data alteration (using Hellinger distances) and level 4 assessed privacy risks (using WP29 criteria).

results87 items were produced on the raw cohort data and then reproduced on each of the four anonymized data. The overall level 1 replication score ranged from 67% to 100% depending on the anonymization solution. The most difficult analyses to replicate were regression models (sub-score ranging from 78% to 100%) and survival analysis (sub-score ranging from 0% to 100. The overall level 2 accuracy score ranged from 22% to 79% depending on the anonymization solution. For level 3, three methods had some variables with different probability distributions (Hellinger distance = 1). For level 4, all methods had reduced the privacy risk of singling out, with relative risk reductions ranging from 41% to 65%.

conclusionNone of the anonymization methods reproduced all outputs and results. A trade-off has to be find between context risk and the usefulness of data to answer the research question.

Identifiers

PMID39899638
PMCPMC11790161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.